Adverum Biotechnologies Inc (NASDAQ:ADVM)

Delayed Data
As of Jun 02
 +0.05 / +4.39%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Adverum Biotechnologies Inc have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 2.00. The median estimate represents a +152.10% increase from the last price of 1.19.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Adverum Biotechnologies Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.40%
Growthannually 23.97%


Growthquarterly -100.00%
Growthannually --
Key to the earnings and sales forecast charts.